ContactPrint • DisclaimerPrivacy PolicyTerms & Conditions

Recent Publications


  • Cappable-seq Service now available !

    In close cooperation with New England Biolabs, Inc. (NEB), VERTIS is now able to make the new Cappable-seq method available to its customers. The method was developed by Laurence Ettwiller and Ira Schildkraut from NEB (Ettwiller, L. et al. 2016. BMC Genomics. 17, 1 (2016), 199).

    It represents the current most sensitive and robust method for the precise identification of bacterial transcription start sites (TSSs).

vertis Biotechnologie AG
Lise-Meitner-Str. 30
D-85354 Freising

Fon +49-(0)8161-18516-11
Fax +49-(0)8161-18516-12

Contact FormHow to find us







Vertis Biotechnologie AG is a research-orientated company in the field of functional genomics. The development and use of new technologies is the company's strength. This strength is closely associated with the ability and knowledge of our team members.

Vertis Biotechnologie AG offers a research orientated surrounding at an attractive location. On our continuous enlargement we are looking for motivated, well trained employees to strengthen our team.

To apply for a job at Vertis Biotechnologie AG send your curriculum vitae to Dr. Fritz Thümmler, CEO. We look forward to hearing from you.
Currently we have no open positions.